C.R.S. § 25.5-5-509

(1) Notwithstanding any provisions of this part 5 to the contrary, for the treatment of a substance use disorder, in promulgating rules, and subject to any necessary federal authorization, the state board shall authorize reimbursement for at least one federal food and drug administration-approved ready-to-use opioid overdose reversal drug without prior authorization. (2) Intentionally left blank —Ed. (a) As used in this subsection (2), unless the context otherwise requires, “opiate antagonist” has the same meaning as set forth in section 12-30-110 (7)(d). (b) A hospital or emergency department shall receive reimbursement under the medical assistance program for the cost of an opiate antagonist if, in accordance with section 12-30-110 , a prescriber, as defined in section 12-30-110 (7)(h), dispenses an opiate antagonist upon discharge to a medical assistance recipient who is at risk of experiencing an opiate-related drug overdose event or to a family member, friend, or other person in a position to assist a medical assistance recipient who is at risk of experiencing an opiate-related drug overdose event. (c) The state department shall seek federal financial participation for the cost of reimbursement for the opiate antagonist, but shall provide reimbursement to the hospital or emergency department for the opiate antagonist using state money until federal financial participation is available.